Group A and C meningococcal polysaccharide vaccines

After vaccination, the body can produce humoral immune response. It is used to prevent epidemic cerebrospinal meningitis caused by group A and group C meningococci.

A small number of people who received this drug experienced brief fever, local redness, swelling, nodules and pain, which resolved on their own.

1. It is contraindicated for those who are known to be allergic to any component of the vaccine. 2. It is contraindicated for those suffering from acute diseases, severe chronic diseases, acute attacks of chronic diseases and fever. 3. It is contraindicated for those with encephalopathy, uncontrolled epilepsy and other progressive neurological diseases.

Drug interactions may occur if used with other drugs. Please consult your doctor or pharmacist for details.

Store and transport at 2-8℃ away from light.

After reconstitution, each bottle contains 0.5 ml, and the dose for one person each time is 0.5 ml, containing 50 μg of group A and group C polysaccharides respectively.

24 months

Zhejiang Tianyuan Bio-pharmaceutical Co., Ltd.

• Founded in:

  1986-12-19

• Address:

  No. 56, Tianhe Road, Economic and Technological Development Zone, Linping District, Hangzhou City, Zhejiang Province

• Tax NO.:

  91330000143833309Q

• Registered Funds:

  1,066.8 million yuan

• Website:

  Log in to view

• Email:

  Log in to view